Screener
Oscar Health OSCR Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 4.1%— | 0.1%— | -3.4%— | —— | —— | |
| Net margin | 3.6%— | -0.3%— | -3.8%— | —— | —— | |
| Returns | ||||||
| Return on equity | 34.3%— | -2.6%— | -44.5%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 1.7×-0.1× | 1.8×-0.2× | 2.1×-0.1× | 2.2×+0.1× | 1.9×+0.4× | |
| Liquidity | ||||||
| Current ratio | 1.1×+0.2× | 1.1×+0.2× | 0.9×+0.1× | 0.9×+0.1× | 0.9×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.3×0.0× | 0.5×+0.1× | 0.7×+0.4× | 0.3×0.0× | |
| Net debt / EBITDA | -5.6×— | -110.6×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $6.15+35.8% | $5.05+15.8% | $3.73-2.3% | $3.95-17.4% | $4.53+21.1% | |
| Valuation | ||||||
| Market capitalization | $10.22B+92.4% | $3.42B+4.0% | $4.14B+24.5% | $4.89B-3.3% | $5.1B+39.3% | |
| Price / earnings | 18.6×— | —— | —— | —— | —— | |
| Price / sales | 0.7×+0.2× | 0.3×-0.1× | 0.4×0.0× | 0.4×-0.2× | 0.5×0.0× | |
| Price / book | 5×-0.2× | 2.1×-0.4× | 4.2×+1.0× | 4.8×+0.4× | 4.4×+1.2× | |
| EV / EBITDA | 10×— | -24.7×— | —— | —— | —— |
FAQ
- Where do Oscar Health's ratios come from?
- Every ratio is computed from Oscar Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
